Tennis Anti-Doping Programme
The International Tennis Federation (ITF) announced today that an independent Tribunal (Tim Kerr QC, sitting alone) has ruled that Alex Bogomolov Jr has been found to have committed a Doping Offence under the ITF’s Tennis Anti-Doping Programme 2005.
A sample collected from Alex Bogomolov Jr at the Australian Open on 13 January 2005 tested positive for salbutamol. The player said he took salbutamol for medical reasons (to treat his exercise induced asthma), but as of the date of the sample collection he did not have a valid Therapeutic Use Exemption (TUE) to cover the treatment. The Tribunal found that there had been no intent to enhance performance by the taking of salbutamol (which is a “Specified Substance” under the World Anti-Doping Code), so that the otherwise mandatory two-year ban under the Programme did not apply. However, the player was found to be at fault for failing to take personal responsibility for ensuring that he had a valid TUE to cover the use of the salbutamol.
As a result, the Tribunal determined that Alex Bogomolov Jr is sanctioned with a one-and-a-half month suspension starting from 26 September 2005, and will forfeit the prize money and ranking points earned at the Australian Open and at subsequent events up to and including the Mexico City Challenger which took place from 4-10 April 2005. Alex Bogomolov Jr will be eligible to return to competition on 10 November 2005. The full decision of the Tribunal is published on the ITF website www.itftennis.com.